NTA Publishes Survey on Preferences for Treatments for NPC Disease

On behalf of the Niemann-Pick Type C Therapy Accelerator (NTA) team, we would like to share with you a recent patient and caregiver survey in order to better understand the experiences of people with Niemann-Pick Type C (NPC) and their preferences for future treatments.  This survey included questions about NPC symptoms, treatments, the impact of the disease on daily life, … Read More